GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Heart Test Laboratories Inc (NAS:HSCS) » Definitions » Ending Cash Position

Heart Test Laboratories (Heart Test Laboratories) Ending Cash Position : $7.08 Mil (As of Jan. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Heart Test Laboratories Ending Cash Position?

Heart Test Laboratories's Ending Cash Position for the quarter that ended in Jan. 2024 was $7.08 Mil.

Heart Test Laboratories's quarterly Ending Cash Position declined from Jul. 2023 ($0.58 Mil) to Oct. 2023 ($0.10 Mil) but then increased from Oct. 2023 ($0.10 Mil) to Jan. 2024 ($7.08 Mil).

Heart Test Laboratories's annual Ending Cash Position increased from Apr. 2021 ($0.72 Mil) to Apr. 2022 ($0.92 Mil) and increased from Apr. 2022 ($0.92 Mil) to Apr. 2023 ($1.66 Mil).


Heart Test Laboratories Ending Cash Position Historical Data

The historical data trend for Heart Test Laboratories's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Heart Test Laboratories Ending Cash Position Chart

Heart Test Laboratories Annual Data
Trend Apr20 Apr21 Apr22 Apr23
Ending Cash Position
0.50 0.72 0.92 1.66

Heart Test Laboratories Quarterly Data
Apr20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.93 1.66 0.58 0.10 7.08

Heart Test Laboratories Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Heart Test Laboratories's Ending Cash Position for the fiscal year that ended in Apr. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=0.918+0.742
=1.66

Heart Test Laboratories's Ending Cash Position for the quarter that ended in Jan. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0.098999999999999+6.977
=7.08


Heart Test Laboratories Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Heart Test Laboratories's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Heart Test Laboratories (Heart Test Laboratories) Business Description

Traded in Other Exchanges
N/A
Address
550 Reserve Street, Suite 360, Southlake, TX, USA, 76092
Heart Test Laboratories Inc is a medical technology company focused on applying innovative AI-based technology to an ECG to expand and improve an ECG's clinical usefulness. The objective of the company is to make an ECG a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings.
Executives
David R. Wells director 2801 OCEAN PARK BLVD., SUITE 339, SANTA MONICA CA 90405
Bruce Bent director 750 BONHAM PARKWAY, LANTANA TX 76226
Mark T Hilz director, officer: See Remarks 3301 DAKOTA DRIVE, NORTHLAKE TX 76226
Patrick Kanouff director 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Brian Szymczak director 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Danielle Watson officer: See Remarks 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Andrew Simpson director, officer: See Remarks 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092